Nuzenio

Tarsus

Tarsus news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 21 publisher sources 100/100 entity strength

Latest news

Tarsus Pharmaceuticals (NASDAQ:TARS) Issues Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:15:52 GMTTarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:11:15 GMTTarsus Strikes Up to $800M Deal for Alkeus, Entering Heated Stargardt Disease Race - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 18:41:00 GMTTarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSciAllSci · Fri, 07 Aug 2026 14:59:09 GMTMizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 14:46:25 GMTTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 13:52:54 GMTTarsus joins Stargardt race to market with $800m Alkeus takeover - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 13:43:10 GMTTarsus to acquire Alkeus Pharma, adding retina repertoire - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 11:54:03 GMT

Timeline

Sat, 08 Aug 2026 04:15:52 GMTTarsus Pharmaceuticals (NASDAQ:TARS) Issues Earnings Results - MarketBeat
Sat, 08 Aug 2026 01:11:15 GMTTarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.st
Fri, 07 Aug 2026 18:41:00 GMTTarsus Strikes Up to $800M Deal for Alkeus, Entering Heated Stargardt Disease Race - finance.biggo.com
Fri, 07 Aug 2026 14:59:09 GMTTarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSci
Fri, 07 Aug 2026 14:46:25 GMTMizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating - marketscreener.com
Fri, 07 Aug 2026 13:52:54 GMTTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million - Pharmaceutical Executive

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tarsus.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

21 distinct publisher/source names are currently connected to this entity page.